ATLANTA, GA – Donald L. Trump, MD, Senior Vice President for Clinical Research at Roswell Park Cancer Institute (RPCI), will lead a scientific discussion titled “Novel Targets in Prostate Cancer” at the 2006 annual meeting of the American Society of Clinical Oncology, June 2-6, Atlanta, GA. The session is scheduled for Sunday, June 4, 4:30 – 6 pm in Building C, Level 1, Hall C3.

Dr. Trump will serve as a discussant and facilitate dialogue following the presentation of a study titled, “Reduced Thromboembolic Events with DN-101 (high dose calcitriol) Treatment of Androgen-Independent Prostate Cancer: Hypothesis for a New Class of Anticoagulant” (abstract #4505). This study examines the potential of a specific form of vitamin D (high-dose calcitriol) as a new class of anticoagulant to reduce serious adverse events such as thromboembolism in prostate cancer patients.

Dr. Trump is past Secretary/Treasurer of ASCO and is a member of numerous professional and scientific societies. His research interests include innovative clinical trials and treatment studies in prostate cancer and anti-tumor mechanism and therapeutic effects of vitamin D. He also is exploring the antiangiogenic effects of high dose calcitriol through preclinical and clinical studies. He holds European and U.S. patents for the use of vitamin D and vitamin D analogues in high dose chemotherapy.

The American Society of Clinical Oncology is the world’s leading professional organization representing physicians of all oncology subspecialties who care for people with cancer. ASCO’s more than 20,000 members from the United States and abroad set the standard for patient care and lead the efforts to discover more effective cancer treatments, increase funding for clinical and translational research, and ultimately, improve cancer care for the estimated 10 million people diagnosed with cancer worldwide each year.

Roswell Park Cancer Institute, founded in 1898, is the nation’s first cancer research, treatment and education center and is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. RPCI is a member of the prestigious National Comprehensive Cancer Network, an alliance of the nation’s leading cancer centers. For more information, visit RPCI’s website at www.roswellpark.org, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.